A clinical trial comparing heavy- and medium-weight surgical mesh for ventral hernia repairs is recruiting patients.
Patients will be included if they have a ventral hernia, are 18 years of age or older, have a defect classified as CDC wound class 1, are able to achieve midline fascial closure, have a hernia defect width less than or equal to 20 cm, can tolerate general anesthesia, and can give informed consent. Patients will be excluded if they have undergone emergent ventral hernia repair, undergone laparoscopic or robotic ventral hernia repair, undergone staged repair of their ventral hernia, or are pregnant at the time of the surgery.
The primary outcome of this trial is pain that will be measured via the in 1 year postoperatively. Other outcomes include hernia recurrence, to be determined via the ; the occurrence of a deep wound infection, to be determined by physical examination and/or computed tomography scanning; and quality of life measured by the questionnaire.
Find more information at .